Ambu (CPSE:AMBU B) Stock Drops Despite Firmer Margins And Earnings Growth

Ambu stock comes into this earnings print under pressure, down about 12% over the last week and slightly lower over the past month, even though the latest quarter shows firmer profitability. Q3 basic earnings per share of 0.59 DKK and net income of 156 million DKK sit on top of a trailing 12 month net profit margin of 8.2% that is higher than last year.

The tension for you as an investor is clear. Short term price weakness is bumping into a multi quarter story of improving earnings power that also feeds into valuation models suggesting a large gap to estimated fair value.

Love Ambu’s improving profitability profile but worried about the recent share price drop? Benchmark your ideas against 272 high quality undervalued stocks.

Q3 2026 Earnings Summary

• Revenue, Q3 2026 vs. Q3 2025: DKK 1,640 million vs. DKK 1,507 million (up about 8.8%)
• Net Income, Q3 2026 vs. Q3 2025: DKK 156 million vs. DKK 123 million (up about 26.8%)
• Basic EPS, Q3 2026 vs. Q3 2025: DKK 0.59 vs. DKK 0.46 (up about 28.3%)
• Net Profit Margin, Trailing 12 Months vs. Prior Year: 8.2% vs. 6.0% (margin higher year over year)

Tired of scrolling through dense earnings tables and PDFs? Get a clear visual read on Ambu’s valuation, growth and profitability trends in the full company report for Ambu.

Evaluating Ambu’s Profit-Led Growth Story

Bullish investors argue that Ambu can turn rising single use endoscopy adoption and manufacturing shifts into a cleaner, profit led growth story. The latest quarter offers some concrete milestones in that direction. Revenue reached DKK 1,640 million with net income of DKK 156 million and basic EPS of DKK 0.59. That now feeds into a trailing 12 month net margin of 8.2%, compared with 6.0% a year earlier, which points to better earnings quality rather than volume only growth.

This margin step up is consistent with expectations that operational changes, including the move of complex production to Mexico, can support profitability as volumes build. It also suggests that Ambu is not relying solely on price or one off factors to support earnings. For a thesis built on scalable, recurring procedure driven revenue, this print moves the company closer to the profit milestones bullish holders want to see.

Compare Ambu’s margin progress and Mexico production shift with how institutions are resetting their expectations. See the consensus price target analysis for Ambu to check whether analyst targets line up with this profit led story.

Ambu’s Cautious Thesis Meets Mixed Execution Signals

The bearish view on Ambu centers on pricing pressure, regulatory risk for single use devices and the possibility that operating leverage disappoints if volumes soften. Recent share price weakness, with the stock down about 12% over 7 days and about 5% over 30 days, suggests investors are leaning toward that caution. The latest quarter shows higher revenue of DKK 1,640 million and net income of DKK 156 million, so the feared near term margin squeeze is not evident here. That means the key bear milestones around visible margin compression and weaker earnings are not hit in this print.

However, the cautious thesis is not invalidated either. There is no disclosed evidence on pricing resilience, procurement pushback or regulatory costs. Without clear volume or market share data, it is hard to say that Ambu has disproved concerns about competitive pressure and operating leverage.

With Ambu trading at DKK66.65 on a trailing P/E of 34.5x and market expectations leaning on strong growth, you should verify whether liquidity, debt and cash generation truly support that valuation. Analyze the full financial health analysis of Ambu stock.

Take Control of Your Next Move

If Ambu’s mix of improving margins and recent share price weakness has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and wait for your preferred entry point. Once you are invested, keep your decisions clear with the Portfolio Command Center that highlights only the most important changes to your holdings. For a longer term view, tap into crowd insights and different angles on Ambu and other stocks through the Community. By spotting hidden catalysts and risks early, you give yourself a better chance to stay ahead of the market.

Seeking Alternatives Beyond Ambu Stock?

Fresh stock ideas can move fast. Breakout potential, fading risks or momentum shifts often get caught late. Scan curated picks before the crowd while it matters and get in early.

• Spot companies quietly building strength before momentum headlines hit by using the curated 291 resilient stocks with low risk scores that surfaces businesses with resilient profiles while they are still under the radar.
• Hunt for early leaders in next generation computing and data security with the focused 24 quantum computing stocks that highlights stocks tied to advanced materials and quantum research themes.
• Target income opportunities by scanning the curated 413 dividend fortresses that highlights companies offering higher yields with an emphasis on durability and balance sheet support.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com